114 related articles for article (PubMed ID: 19923120)
1. Myasthenia gravis and other neuromuscular junction disorders.
Jacob S; Viegas S; Lashley D; Hilton-Jones D
Pract Neurol; 2009 Dec; 9(6):364-71. PubMed ID: 19923120
[No Abstract] [Full Text] [Related]
2. Autoimmune mediated neuromuscular junction defects.
Farrugia ME; Vincent A
Curr Opin Neurol; 2010 Oct; 23(5):489-95. PubMed ID: 20651592
[TBL] [Abstract][Full Text] [Related]
3. Antibody-mediated disorders of neuromuscular transmission.
Vincent A
Suppl Clin Neurophysiol; 2004; 57():147-58. PubMed ID: 16106615
[No Abstract] [Full Text] [Related]
4. [Myasthenia, a model of a disease caused by auto-antibodies].
Goulon M; Gajdos P; Goulon-Goëau C
Ann Med Interne (Paris); 1987; 138(6):444-61. PubMed ID: 2829682
[No Abstract] [Full Text] [Related]
5. [Myasthenia gravis; clinical aspects, pathophysiology and treatment].
Oosterhuis HJ
Ned Tijdschr Geneeskd; 1983 Sep; 127(39):1765-71. PubMed ID: 6314161
[No Abstract] [Full Text] [Related]
6. Update on the evaluation and therapy of autoimmune neuromuscular junction disorders.
Katz J; Barohn RJ
Phys Med Rehabil Clin N Am; 2001 May; 12(2):381-97. PubMed ID: 11345014
[TBL] [Abstract][Full Text] [Related]
7. [Immunologic aspects of disorders of neuromuscular transmission. 2. Experimental autoimmune myasthenia gravis and the Lambert-Eaton myasthenic syndrome].
Andreis I; Lovnićki TJ; Beara N; Taradi M
Lijec Vjesn; 1994; 116(5-6):158-61. PubMed ID: 7968205
[TBL] [Abstract][Full Text] [Related]
8. [Physiopathology of myasthenia gravis. A review (author's transl)].
Bergmans J
Ann Chir; 1980 Mar; 34(3):147-57. PubMed ID: 6245616
[No Abstract] [Full Text] [Related]
9. Intravenous immune globulin in myasthenia gravis.
Gajdos P
Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):49-51. PubMed ID: 8033435
[TBL] [Abstract][Full Text] [Related]
10. Immunopathology of myasthenia gravis.
Drachman DB
Fed Proc; 1979 Nov; 38(12):2613-5. PubMed ID: 227751
[No Abstract] [Full Text] [Related]
11. Cholinergic neuromuscular hyperactivity in patients with myasthenia gravis seropositive for MuSK antibody.
Punga AR; Flink R; Askmark H; Stålberg EV
Muscle Nerve; 2006 Jul; 34(1):111-5. PubMed ID: 16453324
[TBL] [Abstract][Full Text] [Related]
12. How the autoimmune response to acetylcholine receptor impairs neuromuscular transmission in myasthenia gravis and its animal model.
Lindstrom J
Fed Proc; 1978 Dec; 37(14):2828-30. PubMed ID: 214352
[No Abstract] [Full Text] [Related]
13. Unravelling the pathogenesis of myasthenia gravis.
Vincent A
Nat Rev Immunol; 2002 Oct; 2(10):797-804. PubMed ID: 12360217
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune myasthenia gravis in childhood.
Andrews PI
Semin Neurol; 2004 Mar; 24(1):101-10. PubMed ID: 15229797
[TBL] [Abstract][Full Text] [Related]
15. The role of acetylcholine receptor antibodies in myasthenia gravis.
Appel SH; Elias SB; Chauvin P
Fed Proc; 1979 Sep; 38(10):2381-5. PubMed ID: 478014
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune disorders of neuromuscular transmission.
Mahadeva B; Phillips LH; Juel VC
Semin Neurol; 2008 Apr; 28(2):212-27. PubMed ID: 18351523
[TBL] [Abstract][Full Text] [Related]
17. Plasma exchange in myasthenia gravis: electrophysiological studies.
Campbell WW; Leshner RT; Swift TR
Ann Neurol; 1980 Dec; 8(6):584-9. PubMed ID: 6260011
[TBL] [Abstract][Full Text] [Related]
18. Lifetime course of myasthenia gravis.
Grob D; Brunner N; Namba T; Pagala M
Muscle Nerve; 2008 Feb; 37(2):141-9. PubMed ID: 18059039
[TBL] [Abstract][Full Text] [Related]
19. The pathophysiology of penicillamine-induced myasthenia gravis.
Kuncl RW; Pestronk A; Drachman DB; Rechthand E
Ann Neurol; 1986 Dec; 20(6):740-4. PubMed ID: 3813503
[TBL] [Abstract][Full Text] [Related]
20. Myasthenia gravis.
Newsom-Davis J
Ann Ital Med Int; 1988; 3 Suppl 1():32-7. PubMed ID: 3152864
[No Abstract] [Full Text] [Related]
[Next] [New Search]
